UK markets closed

QuantumScape Corporation (QS)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
5.60-0.21 (-3.61%)
At close: 04:00PM EDT
5.61 +0.01 (+0.18%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.80B
Enterprise value 1.89B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.22
Enterprise value/revenue N/A
Enterprise value/EBITDA -7.22

Trading information

Stock price history

Beta (5Y monthly) 4.74
52-week change 3-17.40%
S&P500 52-week change 326.49%
52-week high 313.86
52-week low 34.92
50-day moving average 35.75
200-day moving average 36.48

Share statistics

Avg vol (3-month) 36.29M
Avg vol (10-day) 36.39M
Shares outstanding 5444.87M
Implied shares outstanding 6499.53M
Float 8364.99M
% held by insiders 118.62%
% held by institutions 132.08%
Shares short (30 Apr 2024) 456.88M
Short ratio (30 Apr 2024) 48.18
Short % of float (30 Apr 2024) 415.59%
Short % of shares outstanding (30 Apr 2024) 411.39%
Shares short (prior month 28 Mar 2024) 456.19M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-21.78%
Return on equity (ttm)-36.62%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -456.52M
Net income avi to common (ttm)-461.15M
Diluted EPS (ttm)-0.96
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.01B
Total cash per share (mrq)2.02
Total debt (mrq)98.67M
Total debt/equity (mrq)7.83%
Current ratio (mrq)10.38
Book value per share (mrq)2.52

Cash flow statement

Operating cash flow (ttm)-235.65M
Levered free cash flow (ttm)-153.51M